Semaglutide Shows Early Cardiovascular Benefits in Patients with Obesity and Heart Disease
Hey, guess what? That wonder drug semaglutide isn’t just about weight loss. New research is showing it starts saving hearts way sooner than you think. A fresh secondary analysis, just dropped at the 32nd European Congress on Obesity, says semaglutide’s magic kicks in within three months—before patients even hit the full dose or drop serious … Read more